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Introduction
National immunization systems are important for reducing 
vaccine preventable diseases.1 However, in many resource-
constrained countries, such systems need to be improved. This 
paper describes how Nepal’s polio eradication programme 
expanded its work to aid efforts to control other vaccine- 
diseases and improve Nepal’s disease surveillance and im-
munization systems.
Local setting
Nepal eliminated indigenous polio in 2000 and controlled 
outbreaks caused by polio importations between 2005 and 
2010. The country participated in the certification of wild 
poliovirus elimination in the World Health Organization 
(WHO) South-East Asia Region in 2014.2
Nepal’s polio eradication programme, created in 1998, 
is funded by the Global Polio Eradication Initiative and is af-
filiated with WHO’s Nepal country office. The original aim of 
the programme was to conduct active surveillance for possible 
polio cases and to provide technical assistance and support 
on polio vaccination to the country’s Expanded Programme 
on Immunization (EPI), which is the national immunization 
programme. In 2002, the polio eradication programme had 14 
field-office based surveillance medical officers, who actively 
searched for people with acute flaccid paralysis (AFP), i.e. 
suspected polio cases.3 The programme used these surveillance 
data to guide polio immunization activities, especially mass 
campaigns with oral poliovirus vaccine.
Nepal’s EPI began as a pilot project in three districts in 
1979, and by 1988 had expanded into a nationwide immuniza-
tion system providing Bacillus Calmette–Guérin, diphtheria-
tetanus-pertussis, polio, tetanus and measles vaccines.4,5 In 
2000, EPI was obtaining information on vaccine-preventable 
disease cases, except polio, mainly from Nepal’s health man-
agement information system. This information system collects 
reports of infectious disease cases from all government health 
facilities in Nepal,4,5 but like many other passive surveillance 
systems, it has problems with underreporting, delayed report-
ing or incomplete reporting.4,5
Approach
The elimination of indigenous polio created an opportunity 
to use resources from the polio eradication programme to 
strengthen the efforts to control other vaccine-preventable 
diseases.
In 2003, the polio eradication programme’s AFP surveil-
lance system began collecting data on measles and neonatal 
tetanus cases.4,5 The data collection initially involved weekly 
reports to the polio eradication programme from the staff at 
413 hospitals and major health facilities, including all inpatient 
hospitals, located throughout the country. Surveillance medi-
cal officers made weekly visits to 84 active surveillance sites 
among the 413 health facilities to review records of illnesses 
treated at those facilities and to interview health facility staff 
regarding possible new preventable disease cases. During 
their visits, they also compared their findings to the contents 
of the weekly reports, helped to ensure that blood and stool 
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samples were collected and sent to the 
appropriate laboratories, and trained 
and motivated health workers regarding 
the identification, documentation, and 
reporting of new preventable disease 
cases. Blood samples were collected 
for measles confirmatory testing dur-
ing investigations of suspected measles 
outbreaks. In 2004, the surveillance sys-
tem expanded to include rubella, acute 
encephalitis syndrome and Japanese 
encephalitis.5–7 Due to the similarity in 
clinical presentation between rubella 
and measles, surveillance for rubella 
began by testing for rubella immuno-
globulin (Ig) M in blood samples from 
suspected measles cases that tested nega-
tive for measles IgM.5 To detect acute 
encephalitis syndrome cases, a system 
of 45 sentinel medical facilities, located 
primarily in districts suspected to have 
the highest Japanese encephalitis risk, 
was established through a joint effort 
of the polio eradication programme, 
the Government of Nepal and several 
domestic and international laboratories 
and technical agencies. This sentinel 
system used the same database and 
reverse cold chain for shipping labora-
tory samples as the AFP surveillance 
system. Laboratory testing of blood or 
cerebrospinal fluid samples confirmed 
Japanese encephalitis cases.6,7
Since 2002, the staff from the 
eradication programme have used their 
experience to help improve multiple 
aspects of EPI. They have provided 
continuous training and support to 
EPI staff on issues such as vaccine cold 
chain management, data management, 
and assessment of adverse events. They 
aided the development and implementa-
tion of policy guidelines. They have also 
assisted in supervising and monitoring 
routine immunization activities; assisted 
in microplanning to reach every district; 
enhanced research and grant writing ca-
pabilities; and piloted innovations, such 




In 2014, the surveillance system ac-
tivities had expanded to 299 sites, with 
active surveillance for measles, rubella 
and neonatal tetanus, including weekly 
visits from 15 surveillance medical of-
ficers. The sentinel system for acute 
encephalitis syndrome consisted of 132 
sites. Information from the expanded 
surveillance has helped to guide the 
development and implementation of 
immunization policies. For example, in 
2003, the surveillance system detected 
1536 confirmed measles cases, which 
indicated the need of a vaccination cam-
paign for people younger than 15 years 
(Fig. 1).5 EPI acted on this information 
and with the help of the eradication 
programme launched a measles vac-
cination campaign in 2004–2005. Fol-
lowing the campaign, 45 confirmed 
measles cases were identified in 2006.5 
In 2008, an increase in measles cases, a 
total of 394 confirmed cases, prompted 
a follow-up vaccination campaign in 
2008, targeting children aged 9 months 
to 4 years.8 The detection of additional 
measles cases in 2011, along with several 
years of data indicating a substantial 
burden of rubella, led to a combined 
measles–rubella vaccination campaign 
in 2012–2013 targeting all children 
between the ages of 9 months and 14 
years. Afterwards, EPI introduced ru-
bella vaccine into the country’s routine 
immunization schedule. Subsequently, 
the numbers of confirmed measles and 
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Note: Confirmed measles and rubella cases are suspected measles cases (generalized maculopapular rash and fever plus one of the following: cough, coryza 
or conjunctivitis) with either laboratory confirmation through measles or rubella immunoglobulin M testing or an epidemiological link to a measles or rubella 
outbreak with a laboratory-confirmed case.
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rubella cases have fallen, with only 19 
measles and 37 rubella cases in 2013 
and 2014 combined. However, further 
efforts are needed to achieve the goal of 
eliminating measles in Nepal.8
In 2005, the data from the surveil-
lance system confirmed the finding 
from the health management informa-
tion system that Nepal had met the 
criteria for the elimination of neonatal 
tetanus (< 1 case of neonatal tetanus 
per 1000 live births in every district).4 
The surveillance system has continued 
to monitor for any increase in neonatal 
tetanus cases.
The data from the surveillance sys-
tem also aided the planning of Nepal’s 
first Japanese encephalitis vaccination 
campaign in 2006, by identifying the 
high-risk districts.6 After the campaign, 
surveillance data demonstrated an 84% 
drop (from 864 to 141) in Japanese 
encephalitis cases in these districts.7 
By 2011, EPI had completed Japanese 
encephalitis vaccination campaigns in 
31 high- and moderate-risk districts 
and they had introduced the vaccine 
into routine immunization in those dis-
tricts. In 2016, EPI included nationwide 




Since 2002, staff from the eradica-
tion programme have helped EPI to 
introduce hepatitis B vaccine (2003), 
Haemophilus influenzae type b vaccine 
(2009), inactivated polio vaccine (2014) 
and pneumococcal conjugate vaccine 
(2015), in addition to rubella vaccine 
and Japanese encephalitis vaccine. For 
example, for the introduction of inac-
tivated polio vaccine, staff from both 
programmes worked together on an 
application for support from Gavi, the 
Vaccine Alliance. They planned together 
how to roll out the vaccine, develop 
training materials, and supervise and 
monitor the introduction of the vaccine. 
In 2014, Nepal became the first country, 
among those receiving support from 
Gavi, to introduce this vaccine.9 They 
also planned, organized and executed 
the replacement of trivalent inactivated 
oral polio vaccine with bivalent inac-
tivated vaccine on 17 April 2016. By 
monitoring the replacement, they could 
confirm by 11 May 2016 that all trivalent 
oral polio vaccine had been removed 
from the country’s vaccine storage sites 
and health facilities providing immu-
nizations.
The staff from the eradication pro-
gramme have assisted in the develop-
ment of the Comprehensive multiyear 
plan 2068–2072 (2011–2016)10 and the 
national plan of action on intensification 
of routine immunization.
Between 2001 and 2015, the eradi-
cation programme’s work contributed 
to the increase in vaccination coverage 
among Nepalese children aged 12–23 
months. WHO and the United Nations 
Children’s Fund estimated that the pro-
portion of children who received three 
doses of diphtheria-pertussis-tetanus 
containing vaccine rose from 72% to 
91% and the estimated proportion who 
received one dose of measles vaccine 
rose from 71% to 85%.11
The staff from the eradication pro-
gramme have also assisted in responding 
to other health events, such as dengue 
fever and cholera outbreaks and natural 
disasters. Following the major earth-
quake and subsequent aftershocks in 
April 2015, the staff assisted in moni-
toring for potential disease outbreaks, 
assessed damage to health facilities and 
helped identify needs for disaster relief.12
Discussion
The polio eradication programme in 
Nepal has transitioned from focusing 
solely on polio to working on prevent-
ing other vaccine-preventable diseases. 
This transition has shown how staff and 
assets from an eradication programme 
can both strengthen a country’s im-
munization system and reduce disease 
incidence (Box 1). Several factors con-
tributed to this successful transition, 
including the eradication programme’s 
ability to collaborate with EPI, interna-
tional technical agencies and donors; the 
level of support received from donors 
for the expanded activities; and the 
eradication programme’s well-trained, 
highly capable and motivated staff. Ne-
pal’s immunization system has benefited 
from external assistance. For example, 
Gavi has funded 60–70% of the costs 
of vaccine purchases in the country. 
The total vaccine cost in 2014 was ap-
proximately 6.5 million United States 
dollars. The immunization system has 
also been strengthened by the January 
2016 enactment of the national immu-
nization law that requires that the gov-
ernment allocate adequate funding for 
immunizations and establishes a fund 
for collecting national private sector 
donations for support of EPI.13
Other countries have also enlisted 
their polio eradication programmes in 
their work on other diseases. For ex-
ample, in 2007, Bangladesh and India 
initiated surveillance of Japanese en-
cephalitis with the aid of polio surveil-
lance officers.14 In Nigeria, polio staff 
and their organizational experience 
were used to quickly end an outbreak 
of Ebola virus disease in 2014.15 The 
possibility that polio may be eradicated 
in the next few years suggests that staff 
and assets currently funded by the 
Global Polio Eradication Initiative may 
increasingly become available in other 
areas. Countries should carefully man-
age the transition from polio eradication 
to other immunization and public health 
priorities to ensure that they effectively 
use valuable experience and assets from 
the Global Polio Eradication Initiative 
after the initiative ends.16 ■
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Box 1. Summary of main lessons learnt
• Programmes created specifically to eliminate polio can successfully expand their efforts to 
strengthen immunization systems’ abilities to address other vaccine preventable diseases.
• Expanding polio surveillance systems to detect other vaccine-preventable diseases can 
effectively guide subsequent efforts to improve immunization systems.
• The elimination of polio in a country provides an opportunity to transition polio eradication 
staff, assets and experiences to other projects.
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ملخص
تبني برنامج نيبال للقضاء عىل شلل األطفال
املشكلة تعاين العديد من البلدان من ضعف نظم رصد األمراض 
والتحصني ضدها. وهييئ القضاء عىل مرض شلل األطفال فرصة 
برنامج  خالل  من  املتاحة  املادية  واملقومات  بالعاملني  لالستفادة 
األمراض  من  غريه  عىل  للسيطرة  األطفال  شلل  عىل  القضاء 
األخرى املمكن الوقاية منها من خالل التحصينات، وحتسني نظم 
رصد األمراض والتحصني ضدها.
األسلوب يف عام 2003، بدأ نظام الرصد النشط اخلاص بربنامج 
اإلصابة  حاالت  عن  اإلبالغ  نيبال  يف  األطفال  شلل  عىل  القضاء 
إضافة  ومتت  الوالدة.  حديثي  األطفال  بني  والتيتانوس  باحلصبة 
نظام  إىل  األملانية  واحلصبة  الياباين  الدماغ  التهاب  مرض  حاالت 
تطوير  يف  الربنامج  يف  العاملون  وساعد   .2004 عام  يف  الرصد 
وتنفيذ سياسات التحصني احلكومية، كام ساعدوا يف طرح محالت 
التحصني، وساعدوا يف تدريب العاملني باحلكومة يف اإلبالغ عن 
اإلجراءات املتبعة وإدارة التحصني.
من  لدهيا  املستوطنة  احلاالت  عىل  نيبال  قضت  املحلية  املواقع 
املتفشية  احلاالت  عىل  وسيطرت   ،2000 عام  يف  األطفال  شلل 
الفرتة  الواردة من اخلارج يف  الناجتة عن إصابات شلل األطفال 
2005 و2010. ما بني 
الرصد  أنشطة  توسعت   ،2014 عام  يف  الصلة  ذات  التغّيات 
العادية  بذل جهود نشطة لرصد احلصبة  299 موقًعا، مع  لتشمل 
يف  بام  الوالدة،  حديثي  األطفال  بني  والتيتانوس  األملانية  واحلصبة 
األمراض.  لرصد  طبًيا  خمتًصا   15 من  األسبوعية  الزيارات  ذلك 
ومنذ عام 2002، ساعد العاملون يف برنامج القضاء عىل األمراض 
يف طرح ستة حتصينات جديدة، كام ساعدوا عىل احلصول عىل متويل 
من التحالف العاملي للقاحات والتحصني. كام ساعد العاملون يف 
االستجابة للوقائع الصحية األخرى يف البالد.
القضاء  برنامج  أنشطة  نطاق  املستفادة من خالل توسيع  الدروس 
الرصد  نظم  من  نيبال  حّسنت  فقد  األطفال،  شلل  مرض  عىل 
األمراض  ضد  التحصني  تغطية  من  زادت  كام  لدهيا،  والتحصني 
دعم  استمرار  ومع  بالتحصينات.  منها  للوقاية  القابلة  األخرى 
وثيق  إطار  يف  التعاون  إجراء  املهم  من  كان  فقد  املانحة،  اجلهات 
املهاري  العمل  فريق  عىل  واحلفاظ  املوّسع،  التحصني  برنامج  مع 













当地状况 尼泊尔于 2000 年在全国根除了脊髓灰质炎
并在 2005 年至 2010 年间控制了由于脊髓灰质炎病例
输入引起的疾病爆发。
相关变化 2014 年，监测活动扩展到了 299 个地区，对
麻疹、风疹和新生儿破伤风病例进行主动监测，包括
由 15 名监测医疗人员进行每周随访。 对日本脑炎病
例的哨点监测涵盖 132 个地区。 自 2002 年以来，根
除项目工作人员已帮助引进 6 种新疫苗并获得全球疫









Adaptation du programme d’éradication de la poliomyélite au Népal
Problème De nombreux pays ont des systèmes de vaccination et de 
surveillance des maladies déficients. L’élimination de la poliomyélite 
crée l’occasion d’employer le personnel et les ressources du programme 
d’éradication de la poliomyélite pour contrôler d’autres maladies 
évitables par la vaccination et améliorer les systèmes de vaccination et 
de surveillance des maladies.
Approche En 2003, le système de surveillance active du programme 
népalais d’éradication de la poliomyélite a commencé à rendre compte 
des cas de rougeole et de tétanos néonatal. Les cas d’encéphalite 
japonaise et de rubéole ont été ajoutés au système de surveillance en 
2004. Le personnel du programme a soutenu la création et la mise en 
œuvre de politiques gouvernementales de vaccination, a aidé à lancer 
des campagnes de vaccination et a formé du personnel gouvernemental 
sur les pratiques de signalement et la gestion des vaccins.
Environnement local Le Népal a éradiqué la poliomyélite autochtone 
en 2000 et a su contrôler des flambées de poliomyélite importée en 
2005 et 2010.
Changements significatifs En 2014, les activités de surveillance ont été 
étendues à 299 sites, avec une surveillance active de la rougeole, de la 
rubéole et du tétanos néonatal comprenant des visites hebdomadaires 
de 15 médecins de surveillance. En 2014, le réseau de surveillance 
sentinelle de l’encéphalite japonaise couvrait 132 sites. Depuis 2002, le 
personnel du programme d’éradication a aidé à introduire six nouveaux 
vaccins et à pérenniser les financements provenant de Gavi-L’Alliance du 
vaccin. Ce personnel a également prêté son assistance pour répondre 
à d’autres épisodes sanitaires dans le pays.
Leçons tirées En élargissant les activités de son programme 
d’éradication de la poliomyélite, le Népal a amélioré ses systèmes de 
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surveillance et la couverture vaccinale d’autres maladies évitables 
par la vaccination. Pour cet élargissement, la pérennisation des aides 
des donateurs, une étroite collaboration avec le Programme élargi de 
vaccination et la mobilisation du personnel qualifié du programme 
d’éradication de la poliomyélite ont joué un rôle clé.
Резюме
Адаптация непальской программы по искоренению полиомиелита
Проблема Во многих странах слабо развиты системы наблюдения 
за заболеваниями и иммунизации. Искоренение полиомиелита 
позволит использовать персонал и ресурсы программы 
по искоренению полиомиелита для борьбы с другими 
заболеваниями, предотвращаемыми с помощью вакцинации, и 
улучшить системы наблюдения за заболеваниями и иммунизации.
Подход В 2003 году система активного наблюдения программы 
по искоренению полиомиелита начала отчитываться о случаях 
заболевания корью и неонатальным столбняком. В 2004 году 
наблюдение было распространено на японский энцефалит 
и краснуху. Персонал, участвующий в этой программе, 
содействовал развитию и внедрению правительственных 
политик по иммунизации, помогал развернуть кампании по 
вакцинации и обучал государственных служащих процедурам 
отчетности и обращению с вакцинами.
Местные условия Эндемический полиомиелит в Непале был 
искоренен в 2000 году, а в период между 2005 и 2010 годами 
велась борьба с полиомиелитом, занесенным извне.
Осуществленные перемены В 2014 году эпидемиологический 
надзор был расширен до 299 пунктов, в которых осуществлялось 
активное наблюдение за корью, краснухой, неонатальным 
столбняком, включающее еженедельные визиты 15 медработников 
системы наблюдения. Дозорный эпиднадзор за японским 
энцефалитом осуществлялся силами 132 пунктов. С 2002 года 
персонал программы по искоренению полиомиелита помог 
внедрить шесть новых вакцин и обеспечить финансирование 
со стороны Глобального альянса по проблемам вакцинации и 
иммунизации (GAVI). Персонал также участвовал в реагировании 
на другие события в области здравоохранения в стране.
Выводы Расширение деятельности в рамках программы по 
искоренению полиомиелита позволило улучшить непальские 
системы наблюдения и иммунизации и увеличить охват 
вакцинацией других заболеваний, предотвращаемых с 
помощью вакцинации. Постоянная поддержка доноров, тесное 
сотрудничество с расширенной программой иммунизации и 
удержание высококвалифицированного персонала программы 
по искоренению полиомиелита играли важную роль в этом 
расширении.
Resumen
Adaptación del programa de erradicación de la poliomielitis de Nepal
Situación Muchos países tienen sistemas deficientes de supervisión 
e inmunización de enfermedades. La eliminación de la poliomielitis 
ofrece la oportunidad de utilizar el personal y los activos del programa 
de erradicación de la poliomielitis para controlar otras enfermedades 
prevenibles mediante vacunación, así como para mejorar los sistemas 
de supervisión e inmunización de enfermedades.
Enfoque En 2003, el sistema de supervisión activa del programa de 
erradicación de la poliomielitis de Nepal comenzó a informar sobre 
casos de sarampión y tétanos neonatal. En 2004 se añadieron casos de 
rubéola y encefalitis japonesa al sistema de supervisión. El personal del 
programa contribuyó al desarrollo y a la implementación de políticas 
gubernamentales de inmunización, ayudó a lanzar campañas de 
vacunación y formó a personal público para informar sobre las prácticas 
y la gestión de las vacunas.
Marco regional Nepal eliminó la poliomielitis indígena en el año 2000, 
y controló los brotes provocados por la importación de la poliomielitis 
entre 2005 y 2010.
Cambios importantes En 2014, las actividades de supervisión se 
ampliaron a 299 localizaciones, con supervisión activa del sarampión, la 
rubéola y el tétanos neonatal, incluidas visitas semanales de 15 médicos 
de vigilancia. La vigilancia centinela de encefalitis japonesa se realizó en 
132 localizaciones. Desde 2002, el personal del programa de erradicación 
ha contribuido a la introducción de seis nuevas vacunas y ha ayudado 
a obtener una financiación garantizada por parte de la Gavi, la Vaccine 
Alliance. El personal también ha ayudado a responder ante otros sucesos 
sanitarios acaecidos en el país.
Lecciones aprendidas Mediante la ampliación de las actividades de 
su programa de erradicación de la poliomielitis, Nepal ha mejorado sus 
sistemas de supervisión e inmunización y ha aumentado la cobertura de 
vacunación de otras enfermedades prevenibles mediante vacunación. 
El continuo apoyo de los donantes, una estrecha colaboración con 
el Programa Ampliado de Inmunización y la retención del personal 
cualificado del programa de erradicación de la poliomielitis han sido 
muy importantes para esta ampliación.
References
1. Global vaccine action plan 2011–2020. Geneva: World Health Organization; 2013.
2. Bahl S, Kumar R, Menabde N, Thapa A, McFarland J, Swezy V, et al. Polio-free 
certification and lessons learned–South-East Asia region, March 2014. 
MMWR Morb Mortal Wkly Rep. 2014 Oct 24;63(42):941–6. PMID: 25340910
3. Centers for Disease Control and Prevention (CDC). Progress toward 
poliomyelitis eradication–India, Bangladesh, and Nepal, January 2001-June 
2002. MMWR Morb Mortal Wkly Rep. 2002 Sep 20;51(37):831–3. PMID: 
12353744
4. Vandelaer J, Partridge J, Suvedi BK. Process of neonatal tetanus elimination 
in Nepal. J Public Health (Oxf ). 2009 Dec;31(4):561–5. doi: http://dx.doi.
org/10.1093/pubmed/fdp039 PMID: 19443437
5. Centers for Disease Control and Prevention (CDC). Progress in measles 
control–Nepal, 2000–2006. MMWR Morb Mortal Wkly Rep. 2007 Oct 
5;56(39):1028–31. PMID: 17914331
6. Wierzba TF, Ghimire P, Malla S, Banerjee MK, Shrestha S, Khanal B, et al. 
Laboratory-based Japanese encephalitis surveillance in Nepal and the 
implications for a national immunization strategy. Am J Trop Med Hyg. 2008 
Jun;78(6):1002–6. PMID: 18541784
Bull World Health Organ 2017;95:227–232| doi: http://dx.doi.org/10.2471/BLT.16.173674232
Lessons from the field
Addressing vaccine-preventable diseases in Nepal Krishna P Paudel et al.
7. Upreti SR, Janusz KB, Schluter WW, Bichha RP, Shakya G, Biggerstaff BJ, 
et al. Estimation of the impact of a Japanese encephalitis immunization 
programme with live, attenuated SA 14–14–2 vaccine in Nepal. Am J 
Trop Med Hyg. 2013 Mar;88(3):464–8. doi: http://dx.doi.org/10.4269/
ajtmh.12-0196 PMID: 23358643
8. Khanal S, Sedai TR, Choudary GR, Giri JN, Bohara R, Pant R, et al. Progress 
toward measles elimination – Nepal, 2007–2014. MMWR Morb Mortal Wkly 
Rep. 2016 Mar 04;65(8):206–10. doi: http://dx.doi.org/10.15585/mmwr.
mm6508a3 PMID: 26937619
9. Hasman A, Raaijmakers HC, Noble DJ. Inactivated polio vaccine 
launch in Nepal: a public health milestone. Lancet Glob Health. 2014 
Nov;2(11):e627–8. doi: http://dx.doi.org/10.1016/S2214-109X(14)70324-9 
PMID: 25442682
10. Comprehensive Multi-Year Plan 2068-2072 (2011–2016). Katmandu: 
Department of Health Services: 2011. Available from: http://dohs.gov.np/
wp-content/uploads/chd/Immunization/cMYP_2012_2016_May_2011.pdf 
[cited 2016 Nov 4].
11. Immunization, vaccines and biologicals: data, statistics and graphics. 
Geneva: World Health Organization; 2015. Available from: http://www.who.
int/immunization/monitoring_surveillance/data/en/ [cited 2016 Aug 28].
12. Gulland A. Remote districts are still inaccessible five days after second Nepal 
earthquake. BMJ. 2015 May 18;350:h2691. doi: http://dx.doi.org/10.1136/
bmj.h2691 PMID: 25985347
13. Gnawali D. The making of Nepal’s immunization law. Health Affairs Blog. 
Washington: Project HOPE; 2016. Available from: http://healthaffairs.org/
blog/2016/03/07/the-making-of-nepals-immunization-law/ [cited 2016 
Aug 28].
14. Centers for Disease Control and Prevention (CDC). Expanding poliomyelitis 
and measles surveillance networks to establish surveillance for acute 
meningitis and encephalitis syndromes–Bangladesh, China, and India, 
2006–2008. MMWR Morb Mortal Wkly Rep. 2012 Dec 14;61(49):1008–11. 
PMID: 23235298
15. Shuaib F, Gunnala R, Musa EO, Mahoney FJ, Oguntimehin O, Nguku PM, et 
al.; Centers for Disease Control and Prevention (CDC). Ebola virus disease 
outbreak - Nigeria, July–September 2014. MMWR Morb Mortal Wkly Rep. 
2014 Oct 3;63(39):867–72. PMID: 25275332
16. Cochi SL, Freeman A, Guirguis S, Jafari H, Aylward B. Global polio eradication 
initiative: lessons learned and legacy. J Infect Dis. 2014 Nov 1;210 Suppl 
1:S540–6. doi: http://dx.doi.org/10.1093/infdis/jiu345 PMID: 25316878
